Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way ...
Subcutaneous allergen-specific immunotherapy has long been used in allergic rhinitis and/or asthma and has been recognized to be efficacious. However, owing to the inconvenience of injection and the ...
March 19, 2009 (Washington, DC) — Sublingual and subcutaneous immunotherapy combined in a single protocol for the treatment of seasonal allergic rhinitis and food allergies is more effective than ...
Please provide your email address to receive an email when new articles are posted on . 0.13% of subcutaneous immunotherapy injections led to systemic reactions. 15.8% of systemic reactions in SCIT ...
Immunotherapy, exemplified by Opdivo, enhances cancer treatment by targeting malignant cells using the immune system, offering a more precise approach than traditional therapies. The FDA approved ...
Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for patients with solid tumors. On Dec. 27, 2024, the Food and Drug ...
With Bristol Myers Squibb (BMS) now rolling out the SC version of rival nivolumab (Opdivo Qvantig), the shift from 30-minute intravenous (IV) infusion to 5-minute SC injection could be one of the most ...
MONTREAL, May 27, 2025 /CNW/ - – Bristol Myers Squibb Canada (BMS) today announced that Health Canada has approved OPDIVO ® SC (nivolumab for subcutaneous injection) across all currently authorized ...
From new immunotherapy data to managing pollution's impact on kids' allergies, recent months have held significant developments in the field of allergy and immunology. Here are some of the most ...
Please provide your email address to receive an email when new articles are posted on . Black patients are 46% less likely than white patients to receive sublingual immunotherapy prescriptions for ...
Remote patient monitoring is increasingly used in oncology to support advanced therapies, reducing emergency visits and improving patient outcomes. Subcutaneous immunotherapy offers significant time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results